Overview

A Bioequivalence Study Of AG-013736 Tablets In Healthy Volunteers

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that one 5 mg tablet of axitinib has similar drug concentrations in plasma compared to five 1 mg tablets of axitinib after oral dosing.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Axitinib